KIGALI, Rwanda
BioNTech kicked off construction Thursday of the first manufacturing site for mRNA-based vaccines in Africa in Rwanda’s capital of Kigali, which could ensure equal distribution of vaccines.
The leading biotechnology company signed deals last year with Rwanda and the Senegalese Institut Pasteur de Dakar to set up manufacturing sites.
The company expects to set up additional factories in Senegal and South Africa in close coordination with…
Read the Full Article Here Anadolu
Join our social media accounts to watch exclusive videos and photos
